K. Kirtane

发表

Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity.

Stephanie J. Lee, J. Curtis, R. Engelberg, 2018, Journal of palliative medicine.

Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization

H. Jim, A. Hoogland, B. Gonzalez, 2022, Cancers.

Racial and ethnic disparities in hematologic malignancies.

Stephanie J. Lee, K. Kirtane, 2017, Blood.

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study

Joaquim M Farinhas, C. Chung, M. Schell, 2021, Cancers.

Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)

C. Rodriguez, K. Kirtane, 2018, Front. Oncol..

Leaving footprints, not scars: a qualitative pilot study of Hispanic mothers’ willingness to communicate with dependent children about an advanced cancer diagnosis

R. Palacios, F. Lewis, K. Kirtane, 2019, Supportive Care in Cancer.

Transplant-Associated Thrombotic Microangiopathy Is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal.

M. Sorror, N. Weiss, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Considerations for developing supportive care interventions for survivors of head and neck cancer: A qualitative study

H. Jim, A. Hoogland, B. Gonzalez, 2022, Psycho-oncology.

“I have cancer during COVID; that’s a special category”: a qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic

C. Chung, H. Jim, A. Hoogland, 2022, Supportive Care in Cancer.

T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma

M. Schell, Xuefeng Wang, S. Yoder, 2022, Journal for ImmunoTherapy of Cancer.

Oncology Providers' and Professionals' Experiences With Suicide Risk Screening Among Patients With Head and Neck Cancer: A Qualitative Study

Oliver T. Nguyen, H. Jim, B. Gonzalez, 2022, JCO oncology practice.

Psychosocial characteristics of patients undergoing cellular immunotherapies and their caregivers across time

M. Reblin, Dana Ketcher, F. Locke, 2022, Leukemia & lymphoma.

Transplant-Associated Thrombotic Microangiopathy (TA-TMA) is a Multifactorial Disease Unresponsive to Immunosuppressant Withdrawal Blood Marrow

Stephanie J. Lee, K. Kirtane, S. Hingorani, 2019 .

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead

C. Chung, D. Abate-Daga, H. Elmariah, 2021, Journal for ImmunoTherapy of Cancer.

Change in patients' perceived cognition following chimeric antigen receptor T-cell therapy for lymphoma.

H. Jim, B. Small, R. Jayani, 2022, Transplantation and cellular therapy.

Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma

C. Chung, K. Kirtane, J. Muzaffar, 2021, Cancers.

Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas

J. Welch, A. Mardiros, W. Go, 2022, Journal of clinical medicine.

Emerging Therapies for Radioactive Iodine Refractory Thyroid Cancer

K. Kirtane, M. Roth, 2020, Current Treatment Options in Oncology.

Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score‐matched analysis

K. Kirtane, J. Hallanger-Johnson, S. Naffouje, 2021, Journal of surgical oncology.

Duration of Targeted Therapy in Patients With Advanced Non-small-cell Lung Cancer Identified by Circulating Tumor DNA Analysis.

R. Doebele, C. Baik, K. Reckamp, 2020, Clinical lung cancer.

A phase II trial of pembrolizumab and cabozantinib in patients (pts) with recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC).

D. Shin, Yong Teng, N. Saba, 2022, Journal of Clinical Oncology.

Phase II multi-institutional clinical trial result of concurrent cetuximab and nivolumab in recurrent and/or metastatic head and neck squamous cell carcinoma.

Joaquim M Farinhas, P. Stephens, D. Shin, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

TCR gene-engineered cell therapy for solid tumors.

Elaine Tan, K. Kirtane, Neel Gakhar, 2021, Best practice & research. Clinical haematology.

Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline

Nofisat Ismaila, L. Mell, J. Bauman, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Patient-reported outcomes in acute myeloid leukemia: Where are we now?

G. Lyman, Stephanie J. Lee, R. Walter, 2017, Blood reviews.

77 An NGS assay to identify HLA loss of heterozygosity for future CEA and MSLN logic-gated CAR-T solid tumor protocols designed for reduced on-target, off-tumor toxicity

D. Maloney, M. Borad, S. Kopetz, 2022, Regular and Young Investigator Award Abstracts.

639 BASECAMP-1: Leveraging HLA loss of heterozygosity in solid tumors by NGS to identify patients with relapsed solid tumors for future CEA and MSLN logic-gated Tmod™ CAR T-cell therapy

Matthew J. Frigault, D. Miklos, D. Maloney, 2022, Regular and Young Investigator Award Abstracts.

Promise of Patient-Reported Outcomes, Biometric Data, and Remote Monitoring for Adoptive Cellular Therapy.

H. Jim, B. Gonzalez, K. Kirtane, 2022, JCO clinical cancer informatics.

Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial

D. Shin, K. Magliocca, G. Chen, 2023, Nature Medicine.

263 A2B694, an autologous logic-gated cell therapy targeting mesothelin

M. Borad, S. Kopetz, J. Welch, 2022, Regular and Young Investigator Award Abstracts.

Demographic disparities in receipt of care at a comprehensive cancer center

S. Vadaparampil, R. Amorrortu, D. Rollison, 2023, Cancer medicine.

Patient‐reported outcomes in immunotherapy for head and neck cancer

H. Jim, B. Small, A. Hoogland, 2023, Head & neck.

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer

D. Maloney, M. Borad, T. Welling, 2022, Regular and Young Investigator Award Abstracts.

Monitoring Adverse Effects of Radiation Therapy in Patients With Head and Neck Cancer: The FACT-HN-RAD Patient-Reported Outcome Measure.

D. Cella, N. Rothrock, P. Yadav, 2023, JAMA otolaryngology-- head & neck surgery.

Patient-Reported Outcomes among Multiple Myeloma Patients Treated with Standard of Care Idecabtagene Vicleucel

H. Jim, A. Hoogland, B. Gonzalez, 2023, Cancers.

Leaving footprints, not scars: a qualitative pilot study of Hispanic mothers’ willingness to communicate with dependent children about an advanced cancer diagnosis

F. Lewis, K. Kirtane, E. Loggers, 2019, Supportive Care in Cancer.